CLINICAL_TRIALS
ClinicalTrials.gov record update
An Open Label Study of Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01217697
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:38.222183+00:00
- Published At
- 2017-03-24T00:00:00+00:00
- Record Updated At
- 2017-03-24
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Prostate Neoplasms", "Genital Neoplasms, Male", "Urogenital Neoplasms", "Genital Diseases, Male"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-03-24"- protocolSection.identificationModule.nctId
"NCT01217697"- protocolSection.identificationModule.officialTitle
"An Open Label Study of Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy"- protocolSection.statusModule.overallStatus
"APPROVED_FOR_MARKETING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.